157 related articles for article (PubMed ID: 22120722)
1. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.
Bonnomet A; Syne L; Brysse A; Feyereisen E; Thompson EW; Noël A; Foidart JM; Birembaut P; Polette M; Gilles C
Oncogene; 2012 Aug; 31(33):3741-53. PubMed ID: 22120722
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous Manifestations of Epithelial-Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients.
Tashireva LA; Savelieva OE; Grigoryeva ES; Nikitin YV; Denisov EV; Vtorushin SV; Zavyalova MV; Cherdyntseva NV; Perelmuter VM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801519
[TBL] [Abstract][Full Text] [Related]
3. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
Yu M; Bardia A; Wittner BS; Stott SL; Smas ME; Ting DT; Isakoff SJ; Ciciliano JC; Wells MN; Shah AM; Concannon KF; Donaldson MC; Sequist LV; Brachtel E; Sgroi D; Baselga J; Ramaswamy S; Toner M; Haber DA; Maheswaran S
Science; 2013 Feb; 339(6119):580-4. PubMed ID: 23372014
[TBL] [Abstract][Full Text] [Related]
4. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer.
Škalamera D; Dahmer-Heath M; Stevenson AJ; Pinto C; Shah ET; Daignault SM; Said NA; Davis M; Haass NK; Williams ED; Hollier BG; Thompson EW; Gabrielli B; Gonda TJ
Oncotarget; 2016 Sep; 7(38):61000-61020. PubMed ID: 27876705
[TBL] [Abstract][Full Text] [Related]
6. Targeting circulating tumor cells to prevent metastases.
Gostomczyk K; Marsool MDM; Tayyab H; Pandey A; Borowczak J; Macome F; Chacon J; Dave T; Maniewski M; Szylberg Ł
Hum Cell; 2024 Jan; 37(1):101-120. PubMed ID: 37874534
[TBL] [Abstract][Full Text] [Related]
7. Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis.
Usman S; Waseem NH; Nguyen TKN; Mohsin S; Jamal A; Teh MT; Waseem A
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638469
[TBL] [Abstract][Full Text] [Related]
8. Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction.
Xiong G; Chen J; Zhang G; Wang S; Kawasaki K; Zhu J; Zhang Y; Nagata K; Li Z; Zhou BP; Xu R
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3748-3758. PubMed ID: 32015106
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231).
Naderi R; Gholizadeh-Ghaleh Aziz S; Haghigi-Asl AS
Ann Med Surg (Lond); 2022 Jan; 73():103240. PubMed ID: 35079373
[TBL] [Abstract][Full Text] [Related]
10. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.
Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH
Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224
[TBL] [Abstract][Full Text] [Related]
11. Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody.
Micalizzi DS; Che D; Nicholson BT; Edd JF; Desai N; Lang ER; Toner M; Maheswaran S; Ting DT; Haber DA
Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209563119. PubMed ID: 36256815
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
[TBL] [Abstract][Full Text] [Related]
13. Isolation of Viable Epithelial and Mesenchymal Circulating Tumor Cells from Breast Cancer Patients.
Topa J; Żaczek AJ; Markiewicz A
Methods Mol Biol; 2024; 2752():43-52. PubMed ID: 38194026
[TBL] [Abstract][Full Text] [Related]
14. Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.
Hamelin B; Obradović MMS; Sethi A; Kloc M; Münst S; Beisel C; Eschbach K; Kohler H; Soysal S; Vetter M; Weber WP; Stadler MB; Bentires-Alj M
J Mammary Gland Biol Neoplasia; 2023 Dec; 28(1):26. PubMed ID: 38066300
[TBL] [Abstract][Full Text] [Related]
15. Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary.
Nath B; Bidkar AP; Kumar V; Dalal A; Jolly MK; Ghosh SS; Biswas G
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31404980
[TBL] [Abstract][Full Text] [Related]
16. Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells.
Charpentier M; Martin S
Cancers (Basel); 2013 Nov; 5(4):1545-65. PubMed ID: 24240660
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical evaluation of epithelial-mesenchymal transition in epithelial tumors of dogs and cats.
Furusawa Y; Takahashi M; Shima-Sawa M; Hatai H; Miyoshi N; Yamato O; Yabuki A
J Vet Med Sci; 2021 Sep; 83(9):1363-1368. PubMed ID: 34234057
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial-Mesenchymal Transition.
Martins-Cardoso K; Almeida VH; Bagri KM; Rossi MID; Mermelstein CS; König S; Monteiro RQ
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545405
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231): erratum.
Ann Med Surg (Lond); 2024 Jan; 86(1):630. PubMed ID: 38222727
[TBL] [Abstract][Full Text] [Related]
20. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.
Steinmetz NF; Cho CF; Ablack A; Lewis JD; Manchester M
Nanomedicine (Lond); 2011 Feb; 6(2):351-64. PubMed ID: 21385137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
